ABSTRACT Genetic and biochemical studies on enzymes known to be involved in regulating DNA supercoiling yield a complex spectrum of effects on the Escherichia coli SOS system. Previous studies indicated that only inhibition of DNA gyrase by antibiotics that act on the DNA gyrase A subunit results in turning on the E. coli SOS system. Here we show that coumermycin, an antibiotic that acts on the DNA gyrase B subunit, can also induce. Like nalidixic acid induction, coumermycin induction is dependent on the recBC DNase. In both cases induction apparently results from a response of the cell to the DNA gyrase-inhibitor complex rather than just the loss of DNA gyrase activity. However, unlike induction by the DNA gyrase A-specific antibiotics, coumermycin induction also requires the recF gene product. This demonstrates a functional relationship between DNA gyrase and the recF gene product.
DNA gyrase catalyzes the introduction of negative superhelical twists into double-stranded closed-circular DNA in an ATP-dependent reaction (1) ; in the absence of ATP, gyrase relaxes supercoiled DNA (for reviews see refs. 2 and 3). The enzyme is composed of two subunits, originally identified as targets for two types of antibiotics. The DNA gyrase A subunit is the target of nalidixic and oxolinic acid (4, 5) and has the breakage rejoining activity of the enzyme. In the presence of nalidixic acid DNA gyrase forms a relaxation complex with DNA. The DNA gyrase B subunit mediates energy transduction required in the supercoiling reaction and is the target for novobiocin and coumermycin Al (6) . Inhibition of DNA gyrase by any of these antibiotics threatens the survival of Escherichia coli because DNA synthesis is arrested (7, 8) .
A halt in DNA synthesis leads to the coordinated induction of numerous recA-dependent phenomena, termed SOS functions (for a recent review see ref. 9 ), which promote the survival of E. coli and its phages. SOS functions include an errorprone DNA repair, prophage induction, and inhibition of recBC DNase-mediated DNA degradation. The induction of these phenomena depends on the activation of the constitutively made recA protein to act as a protease and cleave its own repressor (10) and other repressors (11, 12) .
One would expect that interference with DNA gyrase would lead to turning on the SOS system. In fact, treatment of E. coli with nalidixic or oxolinic acid (gyrase A-specific antibiotics) leads to the immediate turn-on of the SOS system (13) . However, we did not observe turn-on by novobiocin, a gyrase B-specific antibiotic (14) , and others have reported no SOS induction when E. coli was treated with other gyrase B-specific antibiotics (coumermycin and chlorobiocin) or when a gyrase B temperaturesensitive mutant was incubated at the restrictive temperature (15, 16) . Here, we have reexamined this discrepancy by using 25 ,ug/ml. Details of procedures used for induction assays can be found in ref. 16 . Data are plotted as anthranilate synthase (ASase) activity per ml of culture. However, specific activities parallel these total activity values. The relative merits of different ways of plotting these data will be discussed elsewhere (16) .
To follow DNA synthesis cells were grown at 37C with shaking in supplemented minimal medium containing ampicillin at 25 ,g/ml and thymidine at 1 pug/ml to a density of 1 sion. Me2SO alone is not an inducer. We examined the effect of Me2SO concentrations up to 2.5% on the activity of various inducing agents. No effect was seen except for coumermycin, for which a progressive inhibition of induction activity is seen as the Me2SO concentration is increased. The kinetics of coumermycin induction are unaltered by Me2SO, but the inhibition may explain why others in the past have been unable to observe coumermycin induction. It is possible to use aqueous stock solutions of coumermycin, but these are unstable to prolonged storage.
RESULTS
Earlier studies of recA induction have relied mainly on tedious indirect assays. To circumvent the difficulties associated with these systems we constructed a gene fusion between the recA control region and the trpED genes on pBR322 derivative plasmid, pCS16. The fusion region of pCS16 is shown in Fig. 1 . This system closely mimics the known behavior of the recA operon in vivo (unpublished data). SOS induction is monitored by assaying the production of ASase, the product of the trpED genes. Different strains carrying pCS16 show 2-to 4-fold variation in ASase activity. These differences are not significant for any of the results described below.
The recA-trp-containing plasmid, pCS16, was used to transform the various E. coli strains listed in Table 1 and SOS inducibility by various DNA gyrase inhibitors was measured. When we examined the inducibility of recA with DNA gyrase inhibitors in a wild-type E. coli strain the expected gyrase A-dependent induction of recA was observed. In addition we found that coumermycin Al, a gyrase B-specific antibiotic, also turned on recA synthesis ( Fig. 2A) . The kinetics of turn-on with coumermycin were distinctly slower than that observed with gyrase A-specific antibiotics and other inducers. This is not due to a delay in uptake of the drug or to the speed at which DNA synthesis is turned off. We find coumermycin, just like gyrase A-specific antibiotics, is able to turn off DNA synthesis within 5 min after addition to E. coli cultures (Fig. 3) .
It is not clear why others in the past have been unable to observe coumermycin induction. The relatively weak response and slow kinetics, while easily detected by our fusion technique, may have been difficult to see by less sensitive techniques. Other possible explanations are discussed in Materials and Methods.
It was disturbing that a typical dose of coumermycin (20 ,ug/ ml) induced recA synthesis, whereas no induction was observed with typical doses (100-300 ,ug/ml) of novobiocin (Fig. 2). This, plus the fact that temperature-sensitive gyrase B mutants failed to show induction at the restrictive temperature (15) Guided by the observations of R. Menzel and M. Gellert that very high doses of novobiocin induce recA protein (personal communication), we studied the effect of novobiocin in our system at concentrations all the way from 100 ,ug/ml to 2.5 mg/ml. Around 1 mg/ml novobiocin a small amount of recA induction is observed. This shows that failure of typical novobiocin doses to induce is due not to some qualitative difference between novobiocin and coumermycin but merely to the fact that novobiocin inhibition of recA synthesis masked its induction. Presumably with coumermycin and other stronger gyrase inhibitors induction is so rapid and pronounced that the simultaneous inhibition goes unnoticed.
One is still left with the puzzle that inhibition by gyrase Aor gyrase B-specific antibiotics leads to recA induction, whereas no induction was seen in a strain with temperature-sensitive gyrase B (15) . To We tested the involvement of various recombination pathways (19) on recA induction mediated by gyrase-antibiotic complexes. As had been reported previously (13) , nalidixic acidmediated SOS induction is not seen in recB-recC-cells (Fig.  4A) . Similarly, coumermycin-mediated induction is also not seen (Fig. 4a) . Recombinational proficiency can be restored to recBrecC-cells by either the introduction of the phage A recombination system or nonallelic suppressor (sbcB-or sbcA-) mutations. These are known to restore SOS induction by nalidixic acid in recB-recC-cells (20, 21) . The results shown in Fig. 4B indicate that, when cells lacking the recBC DNase carry an additional sbcA-mutation, SOS induction by both coumermycin and nalidixic acid is once again observed.
Although the genetic manipulations described above restore the recombinational proficiency of recB-recC-cells, they do not restore recBC DNase activity. Apparently, the role of that enzyme can be replaced by A exonuclease or, in sbcA-cells, by exonuclease VIII (22) . Both of these nucleases are double-strand 5'-3' exonucleases. Presumably it is this activity of the recBC DNase that is important in turning on the E. coli SOS system after both gyrase A and gyrase B inhibition. The situation must be somewhat different in recB-recC-sbcB-cells. Here the loss of exonuclease I, a single-strand exonuclease, is believed to channel recombination intermediates into the recF recombinational pathway. We cannot examine recA induction with pCS16 in recB-recC-sbcB-cells because they are unable to maintain plasmids (23). Instead we chose to examine the recF dependence of induction by gyrase inhibitors.
Coumermycin induction is not seen in recF cells (Fig. 5 ), even when these cells are studied for extended periods of time. In contrast, nalidixic acid induction is unaffected by recF-mutations. The specific requirement for the recF gene product in SOS induction by a gyrase B but not a gyrase A inhibitor implies that the recF gene product has a unique interaction with gyrase B-coumermycin complexes. A recA induction that is totally dependent on the recF gene product has not been reported pre- FIo. 4. Induction of recA-directed ASase synthesis in E. coli recBrecC-and recBW recC-sbcB-strains. E. coli strains M01518 (A) and JC8679 (B) were grown to 1 x 108 cells per ml and treated with coumermycin at 20 jig/ml (.) (24, 25) ]. However, the recF pathway appears to involve unique recombination intermediates; the importance of these needs to be assessed (26, 27) . In addition, recF cells are sensitive to ultraviolet irradiation and there is evidence that the as-yet-unidentified recF gene product plays a role in DNA repair (28 some. Coumermycin treatment results in a slow decrease in the rate of DNA synthesis, which reaches a plateau after 20 min. This decrease parallels the loss in superhelical density. However, when we followed the coumermycin inhibition of total DNA synthesis by continuous labeling (see Fig. 3 ) we did not see the slow turn-off reported by Drlica and Snyder (36 The recF dependence of coumermycin induction ought to be the clue that allows the induction mechanism to be sorted out. However, the absence of a proven function for recF is a serious impediment. In E. coli the gyrB, recF, dnaN, and dnaA genes are located in adjacent positions on the E. coli chromosome (37) . The dnaA gene product is involved in replication initiation, and dnaA-mutants are hypersensitive to gyrase inhibitors (38) . In fact, it has been suggested that the close association of the recF gene with genes known to be involved in DNA replication and recombination implies a similar function for the recF gene product (39) . It is tempting to speculate that, like other genes located in adjacent positions, the products of gyrB, recF, dnaN, and dnaA actually form a functionally significant multiprotein complex. Coumermycin inhibition of this target might then be the step leading to recA induction.
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